Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alps Medical Breakthroughs ETF (SBIO)

Alps Medical Breakthroughs ETF (SBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ALPS Advisors
  • Assets Under Management 93,332,500
  • Shares Outstanding, K 1,850
  • 60-Month Beta 0.79
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 1.17 (2.33%)
  • Most Recent Dividend 1.173 on 12/19/24
  • Management Fee 0.50%
  • INDUSTRY GROUPING:

    ETFs - Healthcare

Options Overview Details

View History
  • Implied Volatility 45.84% (+8.08%)
  • Historical Volatility 27.16%
  • IV Percentile 88%
  • IV Rank 57.45%
  • IV High 70.87% on 04/09/25
  • IV Low 12.03% on 09/05/25
  • Expected Move (DTE 12) 0.64 (1.26%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 5
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 53
  • Open Int (30-Day) 51
  • Expected Range 49.81 to 51.09

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.10 +17.05%
on 11/07/25
50.61 -0.32%
on 12/05/25
+6.71 (+15.33%)
since 11/05/25
3-Month
35.43 +42.39%
on 09/15/25
50.61 -0.32%
on 12/05/25
+13.44 (+36.32%)
since 09/05/25
52-Week
22.33 +125.93%
on 04/09/25
50.61 -0.32%
on 12/05/25
+12.64 (+33.43%)
since 12/05/24

Most Recent Stories

More News
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure

Hunting for upside potential typically reserved for the private equity world? Look no further.

SBIO : 50.45 (+0.60%)
GNOM : 46.88 (-0.20%)
IBB : 171.16 (-0.55%)
Galapagos Announces CFO Exit With No Successor Named Yet: Retail’s Disappointed

The company expects to announce a new CFO “in the coming months.”

SBIO : 50.45 (+0.60%)
SPDW : 44.20 (+0.09%)
GLPG : 31.59 (-0.57%)
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

GURU : 63.67 (+0.24%)
GDOC : 36.11 (-0.71%)
SBIO : 50.45 (+0.60%)
MLTX : 14.90 (-0.63%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

SBIO : 50.45 (+0.60%)
IBB : 171.16 (-0.55%)
GILD : 121.22 (-1.14%)
REGN : 718.36 (-0.61%)
XBI : 123.41 (+0.13%)
2 Unstoppable Growth-Oriented ETFs To Hold for the Long Haul

These funds can take some of the risks out of these exciting but sometimes dangerous sectors.

SBIO : 50.45 (+0.60%)
BLOK : 61.82 (-2.06%)
IONS : 81.68 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Fund Summary

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200...

See More

Key Turning Points

3rd Resistance Point 51.15
2nd Resistance Point 50.88
1st Resistance Point 50.66
Last Price 50.45
1st Support Level 50.18
2nd Support Level 49.91
3rd Support Level 49.70

See More

52-Week High 50.61
Last Price 50.45
Fibonacci 61.8% 39.81
Fibonacci 50% 36.47
Fibonacci 38.2% 33.13
52-Week Low 22.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar